Shoor Vir Singh

Dr. Shoor Vir Singh

Department of Biotechnology, GLA University, Mathura, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2025 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MSManjari Sharma
Manjari Sharma
UKUmesh Kumar
Umesh Kumar
SSShoor Vir Singh
Shoor Vir Singh

1 June 2019 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
MSManju Singh
Manju Singh
Saurabh GuptaSaurabh Gupta
Saurabh Gupta
KCKundan Kumar Chaubey
Kundan Kumar Chaubey
SSShoor Vir Singh
Shoor Vir Singh
JSJagdip Singh Sohal
Jagdip Singh Sohal

29 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
MNManthena Navabharath
Manthena Navabharath
VSVarsha Srivastava
Varsha Srivastava
Saurabh GuptaSaurabh Gupta
Saurabh Gupta
SSShoor Vir Singh
Shoor Vir Singh
SASayeed Ahmad
Sayeed Ahmad
Mycobacterium avium subspecies paratuberculosis (MAP) infection in domestic livestock causes persistent diarrhea, weight loss, and death and is also a potential cause of Crohn’s disease (CD) in humans; notably, treatments against MAP are insufficient, costly, and can cause adverse reactions. Hence, plant-derived bioactive constituents have been taken into consideration in this regard. Herein, we present the results of two bioactive constituents (Solasodine and Ursolic acid) that were evaluated for their safety and efficacy against MAP protein (Dephospho-Coenzyme A kinase (DPCK) by utilizing in vitro assays and different tools of in silico biology. The ADME/t-test, the drug-likeness property test, pharmacophore modelling, and PASS prediction have proven that both the constituents have better binding capacities than the available antibiotic drugs used to target protein inhibition pathways. Through our observations, it can be inferred that these two phytochemicals can be adequately used to treat paratuberculosis, thereby combating inflammatory bowel disorders (IBD) of an autoimmune nature.

1 October 2019 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
KCKundan Kumar Chaubey
Kundan Kumar Chaubey
NGNeeraj Gangwar
Neeraj Gangwar
RPRajveer Singh Pawaiya
Rajveer Singh Pawaiya
GJGaya Prasad Jatav
Gaya Prasad Jatav
JSJagdip Singh Sohal
Jagdip Singh Sohal
SJSujata Jayaraman
Sujata Jayaraman

12 August 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
Saurabh GuptaSaurabh Gupta
Saurabh Gupta
KCKundan Kumar Chaubey
Kundan Kumar Chaubey
PAPrabhat Agarwal
Prabhat Agarwal
JKJ. Todd Kuenstner
J. Todd Kuenstner
Deepak ParasharDeepak Parashar
Deepak Parashar
SSShoor Vir Singh
Shoor Vir Singh

29 January 2024 in Heliyon
Verified
Journal Article
Open access
VPVinay Kumar Pathak
Vinay Kumar Pathak
ISItu Singh
Itu Singh
BSBhawna Sharma
Bhawna Sharma
DTDr Ravindra Purushotam Turankar
Dr Ravindra Purushotam Turankar
MAMamta Arora
Mamta Arora
USUtpal Sengupta
Utpal Sengupta
Leprosy is a disease with spectral clinical manifestations along with two types of reactions, type 1 reaction (T1R) and type 2 reaction (T2R). T1R especially occurs because of the defensive upgradation of cell-mediated immunity (CMI) to M. leprae antigens. T1R is the main cause of disability in leprosy. The role of conventional adaptive T cells has been well studied to understand T1R. A comprehensive understanding of the role of unconventional T cells in the manifestation of inflammation during T1R is crucial and has not been studied. In our study, we found significantly higher plasma levels of TNFα, IL1β, IL17, and IP10 in T1R when compared to non-reaction (NR). Gene expression for cytokines in blood circulation by qPCR showed significantly higher expression of IFNγ, IP10, TNFα, IL6, IL17A and chemokines CCL3, CCR1, CCR5, and CXCR3 in T1R as compared to NR. Frequencies of NKT-like cells (48.7 %) and NK cells (22.3 %) were found significantly higher in T1R in comparison to NR (36.9 %, 18.3 %, respectively) (p = 0.0001). Significantly lower levels of γδT cells (3.32 %) were observed in T1R in comparison to NR (5.16 %). The present study has provided evidence for the first time on the role of plausible unconventional T cells in the immunopathogenesis of T1R in leprosy.